Standard Chemical & Pharmaceutical (TWSE:1720) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

1720 Overzicht aandelen

Standard Chemical & Pharmaceutical Co. Ltd.

1720 fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	0/6
Prestaties in het verleden	2/6
Financiële gezondheid	6/6
Dividenden	4/6

Beloningen

Verhandeld tegen 40.8% onder onze schatting van de reële waarde

Risicoanalyse

Onstabiel dividend track record

Standard Chemical & Pharmaceutical Co. Ltd. Concurrenten

Formosa Laboratories

TWSE:4746

NT$11.9b

SCI Pharmtech

TWSE:4119

NT$10.9b

Synmosa Biopharma

TPEX:4114

NT$15.7b

TTY Biopharm

TPEX:4105

NT$18.4b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Standard Chemical & Pharmaceutical
Historische aandelenkoersen
Huidige aandelenkoers	NT$64.40
52 Week Hoogtepunt	NT$79.40
52 Week Laag	NT$58.10
Bèta	0.13
11 maand verandering	-3.01%
3 maanden verandering	-12.26%
1 Jaar Verandering	-1.83%
33 jaar verandering	69.92%
5 jaar verandering	100.62%
Verandering sinds IPO	196.68%

Recent nieuws en updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14

Recent updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26

Rendement voor aandeelhouders

	1720	TW Pharmaceuticals	TW Markt
7D	-0.2%	1.2%	-0.05%
1Y	-1.8%	15.6%	34.7%

Rendement versus industrie: 1720 presteerde slechter dan de TW Pharmaceuticals -sector, die het afgelopen jaar een rendement van 15.6 % opleverde.

Rendement versus markt: 1720 presteerde slechter dan TW Market, dat het afgelopen jaar een rendement van 34.7 % opleverde.

Prijsvolatiliteit

Is 1720's price volatile compared to industry and market?
1720 volatility
1720 Average Weekly Movement	3.7%
Pharmaceuticals Industry Average Movement	4.9%
Market Average Movement	5.8%
10% most volatile stocks in TW Market	9.3%
10% least volatile stocks in TW Market	3.1%

Stabiele aandelenkoers: 1720 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van 1720 is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1967	n/a	Tzu-Ting Fan	www.standard.com.tw

Standard Chemical & Pharmaceutical Co. Ltd. houdt zich bezig met de productie en verkoop van farmaceutische producten, supplementen en API's in Taiwan. Het bedrijf biedt verschillende farmaceutische producten aan, waaronder geneesmiddelen voor de bloedsomloop, de spijsvertering, de luchtwegen, antihistaminica, C.N.S., stofwisseling, antimicrobiële middelen en geneesmiddelen voor de huid en slijmvliezen, evenals API's voor menselijk en diergeneeskundig gebruik en hulpstoffen.

Standard Chemical & Pharmaceutical Co. Ltd. Samenvatting

Hoe verhouden de winst en inkomsten van Standard Chemical & Pharmaceutical zich tot de beurswaarde?
1720 fundamentele statistieken
Marktkapitalisatie	NT$11.51b
Inkomsten(TTM)	NT$854.07m
Inkomsten(TTM)	NT$6.61b

13.5x

Koers/Winstverhouding

1.7x

P/S-verhouding

Is 1720 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
1720 resultatenrekening (TTM)
Inkomsten	NT$6.61b
Kosten van inkomsten	NT$3.71b
Brutowinst	NT$2.90b
Overige uitgaven	NT$2.05b
Inkomsten	NT$854.07m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	4.78
Brutomarge	43.86%
Nettowinstmarge	12.92%
Schuld/Eigen Vermogen Verhouding	6.6%

Hoe presteerde 1720 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

4.2%

Huidig dividendrendement

56%

Uitbetalingsratio

1720 Overzicht aandelen

Beloningen

Risicoanalyse

Standard Chemical & Pharmaceutical Co. Ltd. Concurrenten

TWSE:4746

NT$11.9b

TWSE:4119

NT$10.9b

TPEX:4114

NT$15.7b

TPEX:4105

NT$18.4b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Second quarter 2024 earnings released: EPS: NT$1.21 (vs NT$1.33 in 2Q 2023)

Standard Chemical & Pharmaceutical Co. Ltd. to Report Q2, 2024 Results on Aug 06, 2024

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Upcoming dividend of NT$2.70 per share

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Dividend of NT$2.70 announced

Recent updates

Second quarter 2024 earnings released: EPS: NT$1.21 (vs NT$1.33 in 2Q 2023)

Standard Chemical & Pharmaceutical Co. Ltd. to Report Q2, 2024 Results on Aug 06, 2024

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Upcoming dividend of NT$2.70 per share

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Dividend of NT$2.70 announced

High number of new directors

First quarter 2024 earnings released: EPS: NT$1.41 (vs NT$1.18 in 1Q 2023)

Standard Chemical & Pharmaceutical Co. Ltd. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: EPS: NT$4.67 (vs NT$4.56 in FY 2022)

Standard Chemical & Pharmaceutical Co. Ltd., Annual General Meeting, Jun 20, 2024

Now 20% overvalued after recent price rise

Now 20% overvalued after recent price rise

Now 21% overvalued after recent price rise

Third quarter 2023 earnings released: EPS: NT$1.25 (vs NT$1.34 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$1.33 (vs NT$1.28 in 2Q 2022)

Upcoming dividend of NT$2.50 per share at 3.8% yield

Standard Chemical & Pharmaceutical Co. Ltd. Elects One Additional Director and One Additional Independent Director

Investor sentiment improves as stock rises 22%

Full year 2022 earnings released: EPS: NT$4.56 (vs NT$3.96 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.34 (vs NT$0.89 in 3Q 2021)

Now 20% undervalued

Now 20% undervalued

Second quarter 2022 earnings released: EPS: NT$1.28 (vs NT$0.93 in 2Q 2021)

Upcoming dividend of NT$2.50 per share

First quarter 2022 earnings released: EPS: NT$0.97 (vs NT$1.17 in 1Q 2021)

Less than half of directors are independent

Standard Chem & Pharm CO., LTD., Annual General Meeting, Jun 21, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS NT$0.89 (vs NT$0.64 in 3Q 2020)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS NT$0.93 (vs NT$0.73 in 2Q 2020)

Upcoming dividend of NT$1.80 per share

First quarter 2021 earnings released: EPS NT$1.17 (vs NT$0.67 in 1Q 2020)

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777) agreed to acquire API synthesis department of Standard Chemical from Standard Chem & Pharm CO., LTD. (TSEC:1720) for TWD 341 million.

Full year 2020 earnings released: EPS NT$2.93 (vs NT$2.11 in FY 2019)

Standard Chem & Pharm CO., LTD., Annual General Meeting, Jun 18, 2021

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

New 90-day low: NT$35.20

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

New 90-day low: NT$36.50

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Third quarter 2020 earnings released: EPS NT$0.64

New 90-day low: NT$37.55

New 90-day low: NT$37.70